http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3877904-D1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17369e28baa208b320799cc7d72a8259
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 1988-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e7c51c2e13dc197cb9b38a5e5597b7
publicationDate 1993-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-3877904-D1
titleOfInvention MEDICINAL PRODUCTS CONTAINING AZELASTIN FOR USE IN THE NOSE AND / OR EYE.
abstract Medicaments for nasal or ocular admin. contain 0.0005-2 wt% of azelastin (I) or its salts. (I) is 4-(4-chlorobenzyl)-2 (perhydro-1-methyl-4-azepinyl) -1(2H)-phthalazinone and is described in DE 2164058 (as an antiallergic agent). The medicaments are formulated as aq. solns., gels, ointments, aerosol suspensions or powders. Solns. contain 0.001-0.1% of a preservative, esp. thiomersal or an alkyl benzyl diemthyl ammonium chloride, and may also contain up to 15% of a water-miscible solvent.
priorityDate 1987-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16684434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452490286

Total number of triples: 40.